SLS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 92 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 34 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| COPJ | SLS | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 90% |
| Stochastic ODDS (%) | 4 days ago 83% | 4 days ago 90% |
| Momentum ODDS (%) | 4 days ago 88% | 4 days ago 87% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 86% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 86% |
| TrendMonth ODDS (%) | 4 days ago 84% | 4 days ago 85% |
| Advances ODDS (%) | 25 days ago 88% | 5 days ago 86% |
| Declines ODDS (%) | 6 days ago 83% | 7 days ago 83% |
| BollingerBands ODDS (%) | 7 days ago 82% | 4 days ago 83% |
| Aroon ODDS (%) | 4 days ago 85% | 5 days ago 84% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TKNQ | 22.49 | 0.26 | +1.17% |
| Amplify TokenizationTechnologyLeadersETF | |||
| OCTU | 30.32 | 0.23 | +0.78% |
| AllianzIM U.S. Equity Buffer15 UncOctETF | |||
| NUW | 13.96 | 0.01 | +0.07% |
| Nuveen AMT-Free Municipal Value Fund | |||
| IDX | 10.89 | N/A | N/A |
| VanEck Indonesia ETF | |||
| FREL | 30.05 | -0.19 | -0.63% |
| Fidelity MSCI Real Estate ETF | |||
A.I.dvisor indicates that over the last year, COPJ has been loosely correlated with MTAL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COPJ jumps, then MTAL could also see price increases.
| Ticker / NAME | Correlation To COPJ | 1D Price Change % | ||
|---|---|---|---|---|
| COPJ | 100% | -0.83% | ||
| MTAL - COPJ | 59% Loosely correlated | +0.69% | ||
| NAK - COPJ | 51% Loosely correlated | +0.72% | ||
| CVV - COPJ | 30% Poorly correlated | +10.75% | ||
| SLS - COPJ | 20% Poorly correlated | -2.72% | ||
| TMQ - COPJ | 15% Poorly correlated | -1.57% | ||
More | ||||